The world has changed because of the COVID-19. Our vision at Kaiku Health has not. Actually, our vision is more palpable than perhaps ever before. We are here to provide personalised digital health intervention for every cancer patient. Digital interventions can improve outcomes of cancer care by optimising symptom management, improving care team workflows and...
Elekta (EKTA-B.ST) announced today that it will further develop its focus on cancer care providers and their patients through its acquisition of Kaiku Health. The Finnish company is best known for its app that monitors patient-reported outcomes, providing intelligent symptom tracking and management for healthcare providers in routine oncology care and studies. The Kaiku Health...
The cooperative research between Kaiku Health and Oulu University Hospital aimed to investigate whether patient-reported symptom data (Patient-Reported Outcomes) could be used as an input for machine learning-based prediction models for early detection of immune-related adverse events (irAEs). The research was published at ASCO Annual Meeting 2020 Online Publication on the 13th of May, 2020....
Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland’s Personalized Health Program. This University of Helsinki coordinated project integrates immuno-oncology (IO) activities at the Universities of Helsinki and Turku, 3 University hospitals and one central hospital, 8 Finnish small or medium...
Kaiku Health, a digital therapeutics company for oncology, has developed a daily symptom monitoring module for COVID-19 patients in co-operation with the leading Swiss university hospital group, the Geneva University Hospitals (HUG). PROHUG, the name of the Kaiku Health service at HUG, will now be used for remote monitoring of patients diagnosed with or suspected...